Medical Tourism Market by Treatment Type (Cardiovascular Treatment, Orthopedic Treatment, Neurological Treatment, Cancer Treatment, Fertility Treatment, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023
- ALL22982
- 185 Pages
- September 2017
- Healthcare
Medical tourism can be defined as an organized travel across international borders with the purpose of availing medical treatment of some form, which may or may not be available in the travelers’ home country. The global medical tourism market accounted for $61,172 million in 2016, and is estimated to reach at $165,345 million by 2023, registering a CAGR of 15.0% from 2017 to 2023.
Medical tourists travel abroad for the maintenance, enhancement, or restoration of their health through affordable healthcare facilities & treatments available in other countries, which are comparatively expensive in their own country. It is also linked with leisure and business travel. Therefore, there are several definitions of medical tourism in the market. Some of them include cosmetic, dental, wellness, and spa services. However, for the purpose of this report, wellness, spa, cosmetic, and dental treatment are excluded from the scope of this study.
Availability of affordable medical care & treatment in developing countries and growth in compliance on international standards drive the market. In addition, availability of latest medical treatments augment market growth. However, limited coverage and lengthy partial reimbursement by payers and epidemic outbreaks restrict the market. Furthermore, wider hospital network under insurance coverage for cashless transaction provides lucrative opportunities to the market players.
The medical tourism market is segmented based treatment type and geography. By treatment type, the market is divided into cardiovascular treatment, orthopedic treatment, neurological treatment, cancer treatment, fertility treatment, and other treatments. By geography, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
This study provides a comprehensive overview of the competitive scenario of the market by profiling key market participants. The service providers profiled in this study include
KEY MARKET BENEFITS FOR STAKEHOLDERS
- The study provides an in-depth analysis of the global medical tourism market and the current trends and future estimations to elucidate the imminent investment pockets.
- It presents a quantitative analysis of the market from 2016 to 2023 to enable stakeholders to capitalize on the prevailing market opportunities.
- Extensive analysis of the market based on application assists to understand the trends in the industry.
- Key market players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
KEY PLAYERS PROFILED IN THE REPORT
- Apollo Hospitals Enterprise Ltd.
- Fortis Healthcare Ltd.
- Asian Heart Institute and Research Centre Pvt. Ltd.
- KPJ Healthcare Berhad
- Barbados Fertility Centre
- NTT Medical Center Tokyo
- Seoul National University Hospital
- UZ Leuven (University Hospitals Leuven)
- Infectious Diseases Partners Pte. Ltd.
- Aditya Birla Memorial Hospital
- Prince Court Medical Centre
- Samitivej Public Company Limited;
KEY MARKET SEGMENTS
By Treatment Type
- Cardiovascular Treatment
- Orthopedic Treatment
- Neurological Treatment
- Cancer Treatment
- Fertility Treatment
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- India
- China
- Indonesia
- Singapore
- Malaysia
- Thailand
- South Korea
- Taiwan
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Venezuela
- Costa Rica
- UAE
- South Africa
- Rest of LAMEA
The other players in the value chain include (profiles not included in the report)
- Bumrungrad International Hospital
- Min-Sheng General Hospital
- Raffles Medical Group
- Bangkok Hospital Medical Center
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. REIMBURSEMENT SCENARIO
3.3.1. Developed regions
3.3.2. Developing regions
3.4. GOVERNMENT REGULATIONS
3.5. TOP PLAYER POSITIONING (2016)
3.6. PORTERS FIVE FORCES ANALYSIS
3.7. MARKET DYNAMICS
3.7.1. Drivers
3.7.1.1. Affordable good quality care
3.7.1.2. Availability of quality care
3.7.1.3. Accessible information and care
3.7.1.4. Assistance and support from government agencies and associations
3.7.2. Restraints
3.7.2.1. Limited coverage and lengthy partial reimbursement by payers
3.7.2.2. Difficulties associated with travel, language barriers, availability, documentation and VISA approval issues
3.7.1. Opportunities
3.7.1.1. Overseas promotional offices is key sources of medical tourists
3.7.1.2. Wider hospital network under insurance coverage for cashless transactions
CHAPTER 4 MEDICAL TOURISM MARKET, BY TREATMENT TYPE
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. CARDIOVASCULAR TREATMENT
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. ORTHOPEDIC TREATMENT
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.4. NEUROLOGICAL TREATMENT
4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
4.5. CANCER TREATMENT
4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast
4.6. FERTILITY TREATMENT
4.6.1. Key market trends
4.6.2. Growth factors and opportunities
4.6.3. Market size and forecast
4.7. OTHER GENERAL TREATMENT
4.7.1. Key market trends
4.7.2. Growth factors and opportunities
4.7.3. Market size and forecast
CHAPTER 5 MEDICAL TOURISM MARKET, BY GEOGRAPHY
5.1. OVERVIEW
5.2. NORTH AMERICA
5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast
5.2.3.1. U.S. market size and forecast
5.2.3.2. Canada market size and forecast
5.2.3.3. Mexico market size and forecast
5.3. EUROPE
5.3.1. Key market trends
5.3.2. Key growth factors and opportunities
5.3.3. Market size and forecast
5.3.3.1. Germany market size and forecast
5.3.3.2. France market size and forecast
5.3.3.3. UK market size and forecast
5.3.3.4. Italy market size and forecast
5.3.3.5. Spain market size and forecast
5.3.3.6. Rest of Europe market size and forecast
5.4. ASIA-PACIFIC
5.4.1. Key market trends
5.4.2. Key growth factors and opportunities
5.4.3. Market size and forecast
5.4.3.1. India market size and forecast
5.4.3.2. China market size and forecast
5.4.3.3. Indonesia market size and forecast
5.4.3.4. Singapore market size and forecast
5.4.3.5. Malaysia market size and forecast
5.4.3.6. Thailand market size and forecast
5.4.3.7. South Korea market size and forecast
5.4.3.8. Taiwan market size and forecast
5.4.3.9. Rest of Asia-Pacific market size and forecast
5.5. LAMEA
5.5.1. Key market trends
5.5.2. Key growth factors and opportunities
5.5.3. Market size and forecast
5.5.3.1. Brazil market size and forecast
5.5.3.1. Venezuela market size and forecast
5.5.3.1. Costa Rica market size and forecast
5.5.3.1. UAE market size and forecast
5.5.3.1. South Africa market size and forecast
5.5.3.1. Rest of LAMEA market size and forecast
CHAPTER 6 COMPANY/ HOSPITAL PROFILES
6.1. APOLLO HOSPITALS ENTERPRISE LIMITED
6.1.1. Company overview
6.1.2. Company snapshot
6.1.3. Operating business segments
6.1.4. Product portfolio
6.1.5. Business performance
6.2. FORTIS HEALTHCARE LIMITED.
6.2.1. Company overview
6.2.2. Company snapshot
6.2.3. Operating business segments
6.2.4. Product portfolio
6.2.5. Business performance
6.3. ASIAN HEART INSTITUTE
6.3.1. Company overview
6.3.2. Company snapshot
6.3.3. Operating business segments
6.3.4. Product portfolio
6.3.5. Business performance
6.4. KPJ HEALTHCARE BERHAD
6.4.1. Company overview
6.4.2. Company snapshot
6.4.3. Operating business segments
6.4.4. Product portfolio
6.4.5. Business performance
6.5. NIT MEDICAL CENTER TOKIO (NMCT)
6.5.1. Company overview
6.5.2. Company snapshot
6.5.3. Operating business segments
6.5.4. Product portfolio
6.5.5. Business performance
6.6. SEOUL NATIONAL UNIVERSITY HOSPITAL (SNUH)
6.6.1. Company overview
6.6.2. Company snapshot
6.6.3. Operating business segments
6.6.4. Product portfolio
6.6.5. Business performance
6.7. UZ LEUVEN
6.7.1. Company overview
6.7.2. Company snapshot
6.7.3. Operating business segments
6.7.4. Product portfolio
6.7.5. Business performance
6.8. INFECTIOUS DISEASES PARTNERS PTE LTD (IDPPL)
6.8.1. Company overview
6.8.2. Company snapshot
6.8.3. Operating business segments
6.8.4. Product portfolio
6.8.5. Business performance
6.9. ADITYA BIRLA MEMORIAL HOSPITAL (ABMH)
6.9.1. Company overview
6.9.2. Company snapshot
6.9.3. Operating business segments
6.9.4. Product portfolio
6.9.5. Business performance
6.10. BARBADOS FERTILITY CENTRE (BFC)
6.10.1. Company overview
6.10.2. Company snapshot
6.10.3. Operating business segments
6.10.4. Product portfolio
6.10.5. Business performance
6.11. PRINCE COURT MEDICAL CENTRE (PCMC)
6.11.1. Company overview
6.11.2. Company snapshot
6.11.3. Operating business segments
6.11.4. Product portfolio
6.11.5. Business performance
6.12. SAMITIVEG PUBLIC COMPANY LIMITED (SPCL)
6.12.1. Company overview
6.12.2. Company snapshot
6.12.3. Operating business segments
6.12.4. Product portfolio
6.12.5. Business performance
LIST OF TABLES
TABLE 1. COST COMPARISON OF SELECTED MEDICAL PROCEDURES IN MAJOR MEDICAL TOURISM DESTINATIONS, 2014 (USD)
TABLE 2. MAJOR SPECIALITIES OF THE KEY MEDICAL TOURSIM DESTINATIONS
TABLE 3. GLOBAL MEDICAL TOURISM MARKET, BY TREATMENT TYPE, 2016-2023 ($BILLION)
TABLE 4. GLOBAL MEDICAL TOURISM MARKET, BY TREATMENT TYPE, 2016-2023 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 5. MEDICAL TOURISM MARKET FOR CARDIOVASCULAR TREATMENT, BY REGION, 2016-2023 ($BILLION)
TABLE 6. MEDICAL TOURISM MARKET FOR CARDIOVASCULAR TREATMENT, BY REGION, 2016-2023 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 7. MEDICAL TOURISM MARKET FOR ORTHOPEDIC TREATMENT, BY REGION, 2016-2023 ($BILLION)
TABLE 8. MEDICAL TOURISM MARKET FOR ORTHOPEDIC TREATMENT, BY REGION, 2016-2023 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 9. MEDICAL TOURISM MARKET FOR NEUROLOGICAL TREATMENT, BY REGION, 2016-2023 ($BILLION)
TABLE 10. MEDICAL TOURISM MARKET FOR NEUROLOGICAL TREATMENT, BY REGION, 2016-2023 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 11. MEDICAL TOURISM MARKET FOR CANCER TREATMENT, BY REGION, 2016-2023 ($BILLION)
TABLE 12. MEDICAL TOURISM MARKET FOR CANCER TREATMENT, BY REGION, 2016-2023 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 13. MEDICAL TOURISM MARKET FOR FERTILITY TREATMENT, BY REGION, 2016-2023 ($BILLION)
TABLE 14. MEDICAL TOURISM MARKET FOR FERTILITY TREATMENT, BY REGION, 2016-2023 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 15. MEDICAL TOURISM MARKET FOR OTHER GENERAL TREATMENT, BY REGION, 2016-2023 ($BILLION)
TABLE 16. MEDICAL TOURISM MARKET FOR OTHER GENERAL TREATMENT, BY REGION, 2016-2023 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 21. NORTH AMERICA MEDICAL TOURISM MARKET, BY TREATMENT TYPES, 2016-2023 ($BILLION)
TABLE 22. NORTH AMERICA MEDICAL TOURISM MARKET, BY TREATMENT TYPES, 2016-2023 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 25. EUROPE MEDICAL TOURISM MARKET, BY TREATMENT TYPES, 2016-2023 ($BILLION)
TABLE 26. EUROPE MEDICAL TOURISM MARKET, BY TREATMENT TYPES, 2016-2023 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 27. ASIA-PACIFIC MEDICAL TOURISM MARKET, BY COUNTRY, 2016-2023 ($BILLION)
TABLE 28. ASIA-PACIFIC MEDICAL TOURISM MARKET, BY COUNTRY, 2016-2023 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 29. ASIA-PACIFIC MEDICAL TOURISM MARKET, BY TREATMENT TYPES, 2016-2023 ($BILLION)
TABLE 30. ASIA-PACIFIC MEDICAL TOURISM MARKET, BY TREATMENT TYPES, 2016-2023 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 31. LAMEA MEDICAL TOURISM MARKET, BY COUNTRY, 2016-2023 ($BILLION)
TABLE 32. LAMEA MEDICAL TOURISM MARKET, BY COUNTRY, 2016-2023 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 33. LAMEA MEDICAL TOURISM MARKET, BY TREATMENT TYPES, 2016-2023 ($BILLION)
TABLE 34. LAMEA MEDICAL TOURISM MARKET, BY TREATMENT TYPES, 2016-2023 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 35. APOLLO HOSPITALS ENTERPRISE LIMITED: COMPANY SNAPSHOT
TABLE 36. APOLLO HOSPITALS ENTERPRISE LIMITED: OPERATING SEGMENTS
TABLE 37. APOLLO HOSPITALS ENTERPRISE LIMITED: PRODUCT PORTFOLIO
TABLE 38. FORTIS HEALTHCARE LIMITED.: COMPANY SNAPSHOT
TABLE 39. FORTIS HEALTHCARE LIMITED.: OPERATING SEGMENTS
TABLE 40. FORTIS HEALTHCARE LIMITED.: PRODUCT PORTFOLIO
TABLE 41. ASIAN HEART INSTITUTE: COMPANY SNAPSHOT
TABLE 42. ASIAN HEART INSTITUTE: OPERATING SEGMENTS
TABLE 43. ASIAN HEART INSTITUTE: PRODUCT PORTFOLIO
TABLE 44. KPJ HEALTHCARE BERHAD : COMPANY SNAPSHOT
TABLE 45. KPJ HEALTHCARE BERHAD: OPERATING SEGMENTS
TABLE 46. KPJ HEALTHCARE BERHAD: PRODUCT PORTFOLIO
TABLE 47. NMCT: COMPANY SNAPSHOT
TABLE 48. NMCT: OPERATING SEGMENTS
TABLE 49. NMCT: PRODUCT PORTFOLIO:
TABLE 50. SNUH : COMPANY SNAPSHOT
TABLE 51. SNUH: OPERATING SEGMENTS
TABLE 52. SNUH: PRODUCT PORTFOLIO
TABLE 53. UZ LEUVEN : COMPANY SNAPSHOT
TABLE 54. UZ LEUVEN : OPERATING SEGMENTS
TABLE 55. UZ LEUVEN : PRODUCT PORTFOLIO
TABLE 56. IDPPL: COMPANY SNAPSHOT
TABLE 57. IDPPL: OPERATING SEGMENTS
TABLE 58. IDPPL: PRODUCT PORTFOLIO
TABLE 59. ABMH: COMPANY SNAPSHOT
TABLE 60. ABMH OPERATING SEGMENTS
TABLE 61. ABMH PRODUCT PORTFOLIO
TABLE 62. BFC: SNAPSHOT
TABLE 63. BFC: OPERATING SEGMENTS
TABLE 64. BFC: PRODUCT PORTFOLIO
TABLE 65. PCMC: SNAPSHOT
TABLE 66. PCMC: OPERATING SEGMENTS
TABLE 67. PCMC: PRODUCT PORTFOLIO
TABLE 68. SPCL: SNAPSHOT
TABLE 69. SPCL: OPERATING SEGMENTS
TABLE 70. SPCL: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 1. MEDICAL TOURISM MARKET SEGMENTATION
FIGURE 2. TOP INVESTMENT POCKETS: GLOBAL MEDICAL TOURISM MARKET, BY APPLICATION
FIGURE 3. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 4. TOP WINNING STRATEGIES: NATURE AND COMPANY
FIGURE 5. BARGAINING POWER OF BUYERS
FIGURE 6. BARGAINING POWER OF SUPPLIERS
FIGURE 7. THREAT OF NEW ENTRANTS
FIGURE 8. THREAT OF SUBSTITUTION
FIGURE 9. COMPETITIVE RIVALRY
FIGURE 10. MEDICAL TOURISM MARKET, BY TYPE
FIGURE 11. U.S. MEDICAL TOURISM MARKET, 2016-2023 ($BILLION AND NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 12. CANADA MEDICAL TOURISM MARKET, 2016-2023 ($BILLION AND NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 13. MEXICO MEDICAL TOURISM MARKET, 2016-2023 ($BILLION AND NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 14. GERMANY MEDICAL TOURISM MARKET, 2016-2023 ($BILLION AND NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 15. FRANCE MEDICAL TOURISM MARKET, 2016-2023 ($BILLION AND NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 16. UK MEDICAL TOURISM MARKET, 2016-2023 ($BILLION NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 17. ITALY MEDICAL TOURISM MARKET, 2016-2023 ($BILLION AND NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 18. SPAIN MEDICAL TOURISM MARKET, 2016-2023 ($BILLION AND NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 19. REST OF EUROPE MEDICAL TOURISM MARKET, 2016-2023 ($BILLION AND NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 20. INDIA MEDICAL TOURISM MARKET, 2016-2023 ($BILLION AND NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 21. CHINA MEDICAL TOURISM MARKET, 2016-2023 ($BILLION AND NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 22. INDONESIA MEDICAL TOURISM MARKET, 2016-2023 ($BILLION AND NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 23. SINGAPORE MEDICAL TOURISM MARKET, 2016-2023 ($BILLION AND NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 24. MALAYSIA MEDICAL TOURISM MARKET, 2016-2023 ($BILLION AND NUMBER OF PATIENTS IN THOUSANDS))
FIGURE 25. THAILAND MEDICAL TOURISM MARKET, 2016-2023 ($BILLION AND NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 26. SOUTH KOREA MEDICAL TOURISM MARKET, 2016-2023 ($BILLION AND NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 27. TAIWAN MEDICAL TOURISM MARKET, 2016-2023 ($BILLION AND NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 28. REST OF ASIA-PACIFIC MEDICAL TOURISM MARKET, 2016-2023 ($BILLION AND NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 29. BRAZIL MEDICAL TOURISM MARKET, 2016-2023 ($BILLION AND NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 30. VENEZUELA MEDICAL TOURISM MARKET, 2016-2023 ($BILLION AND NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 31. COSTA RICA MEDICAL TOURISM MARKET, 2016-2023 ($BILLION AND NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 32. UAE MEDICAL TOURISM MARKET, 2016-2023 ($BILLION AND NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 33. SOUTH AFRICA MEDICAL TOURISM MARKET, 2016-2023 ($BILLION AND NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 34. REST OF LAMEA MEDICAL TOURISM MARKET, 2016-2023 ($BILLION AND NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 35. APOLLO HOSPITALS ENTERPRISE LIMITED: REVENUE, 2014-2016 ($MILLION)
FIGURE 36. APOLLO HOSPITALS ENTERPRISE LIMITED: REVENUE SHARE, BY SEGMENT, 2016 (%)
FIGURE 37. APOLLO HOSPITALS ENTERPRISE LIMITED: REVENUE SHARE, BY GEOGRAPHY, 2016 (%)
FIGURE 38. FORTIS HEALTHCARE LIMITED.:.: REVENUE, 2014-2016 ($MILLION)
FIGURE 39. FORTIS HEALTHCARE LIMITED.:.: REVENUE SHARE, BY SEGMENT, 2016 (%)
FIGURE 40. FORTIS HEALTHCARE LIMITED.: REVENUE SHARE, BY GEOGRAPHY, 2016 (%)
FIGURE 41. ASIAN HEART INSTITUTE: REVENUE, 2014-2016 ($MILLION)
FIGURE 42. ASIAN HEART INSTITUTE: REVENUE SHARE, BY SEGMENT, 2016 (%)
FIGURE 43. ASIAN HEART INSTITUTE: REVENUE SHARE, BY GEOGRAPHY, 2016 (%)
FIGURE 44. KPJ HEALTHCARE BERHAD: REVENUE, 2014-2016 ($MILLION)
FIGURE 45. KPJ HEALTHCARE BERHAD: REVENUE SHARE, BY SEGMENT, 2016 (%)
FIGURE 46. KPJ HEALTHCARE BERHAD: REVENUE SHARE, BY GEOGRAPHY, 2016 (%)
FIGURE 47. NMCT: REVENUE, 2014-2016 ($MILLION)
FIGURE 48. NMCT: REVENUE SHARE, BY SEGMENT, 2016 (%)
FIGURE 49. NMCT: REVENUE SHARE, BY GEOGRAPHY, 2016 (%)
FIGURE 50. SNUH: REVENUE, 2014-2016 ($MILLION)
FIGURE 51. SNUH: REVENUE SHARE, BY SEGMENT, 2016 (%)
FIGURE 52. SNUH: REVENUE SHARE, BY GEOGRAPHY, 2016 (%)
FIGURE 53. UZ LEUVEN : REVENUE, 2014-2016 ($MILLION)
FIGURE 54. UZ LEUVEN: REVENUE SHARE, BY SEGMENT, 2016 (%)
FIGURE 55. UZ LEUVEN: REVENUE SHARE, BY GEOGRAPHY, 2016 (%)
FIGURE 56. IDPPL: REVENUE, 2014-2016 ($MILLION)
FIGURE 57. IDPPL: REVENUE SHARE, BY SEGMENT, 2016 (%)
FIGURE 58. IDPPL: REVENUE SHARE, BY GEOGRAPHY, 2016 (%)
FIGURE 59. ABMH REVENUE, 2014-2016 ($MILLION)
FIGURE 60. ABMH: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 61. ABMH: REVENUE SHARE, BY GEOGRAPHY, 2016 (%)
FIGURE 62. BFC: REVENUE, 2014-2016 ($MILLION)
FIGURE 63. BFC: REVENUE SHARE, BY SEGMENT, 2016 (%)
FIGURE 64. BFC: REVENUE SHARE, BY GEOGRAPHY, 2016 (%)
FIGURE 65. PCMC: REVENUE, 2014-2016 ($MILLION)
FIGURE 66. PCMC: REVENUE SHARE, BY SEGMENT, 2016 (%)
FIGURE 67. PCMC: REVENUE SHARE, BY GEOGRAPHY, 2016 (%)
FIGURE 68. SPCL: REVENUE, 2014-2016 ($MILLION)
FIGURE 69. SPCL: REVENUE SHARE, BY SEGMENT, 2016 (%)
FIGURE 70. SPCL: REVENUE SHARE, BY GEOGRAPHY, 2016 (%)
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
